Who owns Astellas Pharma Inc Adrf Unspo adr?
- Ticker: ALPMY
- CUSIP Number: 04623u102
Tip: Access positions for across all investors
Analyze quarterly positions in Astellas Pharma Inc Adrf Unspo with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Astellas Pharma Inc Adrf Unspo stock
Who bought or sold Astellas Pharma Inc Adrf Unspo adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rhumbline Advisers | 34k | $410k | -1% | Dec 2023 |
|
| GAMMA Investing | 2.4k | $26k | 864% | Mar 2024 |
|
| Cassady Schiller Wealth Management | 698.00 | $8.3k | 0% | Dec 2023 |
|
| Pnc Financial Services | 253.00 | $3.0k | 52% | Dec 2023 |
|
| FTB Advisors | 114.00 | $1.4k | 0% | Dec 2023 |
|
| Operose Advisors | 90.00 | $1.1k | 0% | Dec 2023 |
|
Who sold out of Astellas Pharma Inc Adrf Unspo?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Group | Sep 2023 | 392k | $5.4M |
| MAI Wealth Advisors | Sep 2023 | 19k | $264k |
| Bp Wealth Management | Sep 2023 | 11k | $145k |
| Russell Investments | Sep 2023 | 783.00 | $11k |